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Pedrino GR, Calderon AS, Andrade MA, Cravo SL, Toney
GM. Discharge of RVLM vasomotor neurons is not increased in
anesthetized angiotensin II-salt hypertensive rats. Am J Physiol Heart
Circ Physiol 305: H1781–H1789, 2013. First published October 11,
2013; doi:10.1152/ajpheart.00657.2013.—Neurons of the rostral ven-
trolateral medulla (RVLM) are critical for generating and regulating
sympathetic nerve activity (SNA). Systemic administration of ANG II
combined with a high-salt diet induces hypertension that is postulated to
involve elevated SNA. However, a functional role for RVLM vasomotor
neurons in ANG II-salt hypertension has not been established. Here we
tested the hypothesis that RVLM vasomotor neurons have exaggerated
resting discharge in rats with ANG II-salt hypertension. Rats in the
hypertensive (HT) group consumed a high-salt (2% NaCl) diet and
received an infusion of ANG II (150 ng·kg1·min1 sc) for 14 days. Rats
in the normotensive (NT) group consumed a normal salt (0.4% NaCl) diet
and were infused with normal saline. Telemetric recordings in conscious
rats revealed that mean arterial pressure (MAP) was significantly in-
creased in HT compared with NT rats (P  0.001). Under anesthesia
(urethane/chloralose), MAP remained elevated in HT compared with NT
rats (P  0.01). Extracellular single unit recordings in HT (n  28) and
NT (n  22) rats revealed that barosensitive RVLM neurons in both
groups (HT, 23 cells; NT, 34 cells) had similar cardiac rhythmicity and
resting discharge. However, a greater (P  0.01) increase of MAP was
needed to silence discharge of neurons in HT (17 cells, 44  5 mmHg)
than in NT (28 cells, 29  3 mmHg) rats. Maximum firing rates during
arterial baroreceptor unloading were similar across groups. We conclude
that heightened resting discharge of sympathoexcitatory RVLM neurons
is not required for maintenance of neurogenic ANG II-salt hypertension.
angiotensin II; high-salt diet; hypertension; rostral ventrolateral me-
dulla vasomotor neurons; single unit recording; sympathetic nerve
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CHRONICALLY ELEVATED ARTERIAL blood pressure (ABP; i.e.,
hypertension) is among the most common disorders affecting
human health and is a leading risk factor for cerebrovascular
and ischemic heart disease, cardiac and renal failure, myocar-
dial infarction, and stroke (69). Studies performed in rats have
shown that raising the plasma concentration of the hormone
ANG II in combination with high salt intake induces hyper-
tension (ANG II-salt hypertension) that is maintained by on-
going sympathetic nerve activity (SNA) (40). The latter is
consistent with reports that ANG II-salt hypertension is accom-
panied by increased plasma norepinephrine concentration (29)
and prevented by sympathetic denervation of splanchnic or-
gans by celiac ganglionectomy (30).
Neuroanatomical studies demonstrate that sympathetic pre-
ganglionic neurons in the spinal cord receive direct input from
at least five distinct brain regions, including the hypothalamic
paraventricular nucleus (PVN), A5 noradrenergic cell group,
caudal raphe region, rostral ventromedial medulla, and rostral
ventrolateral medulla (RVLM) (27, 52, 62, 63). Of particular
importance for the present study are neurons of the RVLM,
which play a critical role in both the generation of SNA and its
dynamic regulation by visceral afferent reflexes, most notably
the arterial baroreceptor reflex (23). Because RVLM neuronal
activity is considered an essential determinant of resting ABP
(3, 21, 22, 37), experiments were performed to test the hypoth-
esis that sympathoexcitatory RVLM neurons with arterial baro-
receptor inhibitable discharge have exaggerated spike fre-
quency in rats with established ANG II-salt hypertension. This
possibility is consistent with evidence that ANG II actions
drive excitatory oxidative stress in the RVLM of renovascular
hypertensive rats (38) and with evidence that intact RVLM
function is essential for increased sympathetic tone in sponta-
neously hypertensive rats (SHR) (11, 19). Additional support
for possible enhancement of RVLM vasomotor neuron dis-
charge in ANG II-salt hypertension derives from evidence that
elevated salt intake is associated with hyper-reactivity of
RVLM control of SNA and ABP (2, 24, 42). The latter is
reflected in exaggerated SNA and ABP responses to chemical
excitation and inhibition of RVLM (2).
In light of available evidence, we hypothesized that identi-
fied sympathoexcitatory RVLM vasomotor neurons will ex-
hibit increased resting discharge in rats with ANG II-salt
hypertension compared with normotensive (NT) controls. We
further hypothesized that discharge in HT rats would be further
enhanced when cardiac rhythmic inhibition was withdrawn by
unloading arterial baroreceptors. Determining the contribution
of RVLM neurons in mediating ANG II-salt hypertension is an
important step toward the goal of identifying molecular and
cellular mechanisms that underlie neurogenic contributions to
arterial hypertension.
METHODS
Animals. Experiments were performed on 50 male Sprague-Dawley
rats (Charles River Laboratories) weighing 350–455 g. Rats were
housed in a temperature-controlled room (22°-23°C) on a 14:10
light-dark cycle and had ad libitum access to food and tap water
throughout the study. All experimental and surgical procedures were
approved by the Institutional Animal Care and Use Committee of the
University of Texas Health Science Center at San Antonio and were
performed in strict accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Control rats in the NT group (n  22) consumed a normal salt diet
containing 0.4% NaCl. Rats in the hypertensive (HT) group (n  28)
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consumed a high-salt diet that contained 2.0% NaCl (Research Diets,
New Brunswick, NJ). Nutrient content of normal and high-salt diets
was otherwise identical.
Recording mean arterial pressure in conscious rats. Radio telem-
etry was used to record mean arterial pressure (MAP) and monitor the
development of ANG II-salt HT in conscious rats as previously
described (12). Briefly, telemetry transmitters (TA11PAC40; Data
Sciences, St. Paul, MN) were implanted while rats were anesthetized
with isoflurane (2% in 100% O2). A ventral midline laparotomy was
performed, and the transmitter catheter was placed into the abdominal
aorta and secured with tissue adhesive (Vetbond; 3M Animal Care
Products, St. Paul, MN). Each transmitter was secured to the abdom-
inal wall with suture. Incisions were closed, and animals were placed
on a heating pad to maintain body temperature during recovery. Rats
each received post-operative antibiotic (G benzathine, 150,000
units/kg sc; AgriLabs, St. Joseph, MO) and analgesic (buprenorphine
hydrochloride, 0.05 mg/kg sc; Sigma-Aldrich, St. Louis, MO) treat-
ments and were given 1 wk to recover before recording baseline ABP
and heart rate (HR).
Infusion of ANG II or vehicle. After 1 wk of baseline recording,
each rat received a subcutaneous osmotic minipump (model 2ML2;
Alzet, Cupertino, CA) that delivered either ANG II (Sigma-Aldrich,
St. Louis, MO) or vehicle for 14 days. ANG II was delivered at a rate
of 150 ng·kg1·min1. Normotensive control rats were either un-
treated (n  13) or received an osmotic minipump containing normal
saline (0.15 M NaCl) (n  9).
In vivo single-unit recordings. On the day of experiments, rats were
anesthetized with isoflurane (3% in O2) and prepared for single unit
extracellular recording as previously described (13, 61, 68). Catheters
were inserted into both femoral veins for administration of drugs, and
into the right femoral or brachial artery for measurement of ABP. Rats
were removed from isoflurane, and anesthesia was maintained with a
cocktail of -chloralose (80 mg/kg iv) and urethane (800 mg/kg iv)
(Sigma-Aldrich). Throughout each experiment, supplemental doses of
anesthetic were given when needed. After tracheal cannulation, rats
were artificially ventilated with oxygen-enriched room air and para-
lyzed with gallamine triethiodide (25 mg/kg bolus, 7 mg·kg1·min1;
Sigma-Aldrich) in D5W. End tidal pCO2 was monitored throughout
each experiment and maintained at 40  10 mmHg by adjusting
ventilation rate and/or tidal volume. Signals were amplified (5k-10k),
band-pass filtered (30–1,000 Hz), and digitized at a frequency of
2,500 Hz using a micro 1401 (Cambridge Electronics Design, Cam-
bridge, UK). Body temperature was maintained at 37  1.0°C with a
heated water-circulating pad.
Rats were placed in a stereotaxic head frame, and the skull was
leveled between bregma and lambda. A craniotomy was performed to
access the RVLM, which was located by mapping the caudal pole of
the facial nucleus by recording the antidromic field potential evoked
by stimulating (1 mA, 0.1 ms, 1 Hz) the mandibular branch of the
facial nerve (CN VII) as previously described (9, 68). Extracellular
single-unit recordings were performed using glass microelectrodes
filled with isotonic saline containing either 2% Chicago Sky Blue or
5% biotinamide (Vector Laboratories, Burlingame, CA). Electrode tip
resistance ranged from 20 to 40 M measured in vivo against a
Ag-AgCl reference electrode. Individual RVLM neurons with axons
projecting to the spinal cord were identified by antidromic activation.
This was achieved by electrical stimulation (1–3 mA, 0.1 ms) of the
dorsolateral funiculus at the T2 segment using a concentric bipolar
electrode (250 m od) as previously described (12, 13). Standard
criteria were used to verify the antidromic nature of evoked spikes
(32). These included having 1) invariant onset latency, 2) the ability
to faithfully respond to high frequency stimulation, and 3) the ability
of spontaneous action potentials to cancel evoked spikes (i.e., the
collision test). To determine whether neurons were baro-inhibitable,
ABP was increased with a pressor dose of phenylephrine (10 g/kg;
Sigma-Aldrich) or an inflatable cuff placed suprarenal around the
abdominal aorta. All data were digitalized using a micro1401 and
analyzed off-line with compatible Spike2 software (v5.15; Cambridge
Electronics Design, Cambridge, UK).
Juxtacellular labeling and histology. Upon completion of electro-
physiological characterization, a subgroup of neurons was filled with
biotinamide using the juxtacellular labeling technique as previously
described (53, 67). Briefly, positive polarity current pulses (200 ms
duration, 50% duty cycle) of graded amplitude (range: 0.5–6 nA)
were delivered through the recording electrode to entrain discharge
for 2–10 min while electrostatically ejecting biotinamide from the
electrode filling solution. Current pulses were then halted, and recov-
ery of discharge was noted to confirm the viability of entrained
neurons. After recovering for 1–4 h, rats underwent transcardiac
perfusion with 0.1 M PBS (100 ml) followed by 4% paraformalde-
hyde (300 ml, pH 7.4) in 0.1 M PBS. Brains were removed and
post-fixed in 4% paraformaldehyde for 1 to 2 h, cryoprotected in 30%
sucrose-PBS, and sectioned to a thickness of 40 m. To visualize
biotin-filled neurons, free floating sections were incubated with
streptavidin conjugated to Alexa Fluor 488 (1:250; Invitrogen, Carls-
bad, CA) at room temperature for 3 h. To assess if filled cells
belonged to the C1 adrenergic cell group, double labeling was per-
formed for the presence of the enzyme phenylethanolamine-N-methyl
transferase (PNMT) using a polyclonal antibody (1:1,500; Milipore,
Billerica, MA) and Alexa Fluor 594-conjugated to a donkey anti-
rabbit IgG (1:300; Invitrogen) (53). Sections were mounted on slides
in sequential rostrocaudal order and covered with Prolong Gold
Anti-fade Reagent (Invitrogen, Carlsbad, CA). Sections were viewed
through a transmission fluorescence microscope (Olympus BX41),
and digital images were acquired with a Spot charge-coupled device
camera (Diagnostic Instruments).
Data analysis and statistics. MAP and HR responses to ANG II
plus high salt intake versus sham treatment were compared by two-
way ANOVA (Prism 5.01; GraphPad, La Jolla, CA). Pair-wise com-
parisons were made with Bonferroni post hoc tests. Group differences
in MAP and HR under anesthesia were compared with unpaired
t-tests. Basal discharge frequency of RVLM neurons was determined
from rate meter records (1-s bins) over a representative 5-min data
segment while ABP was stable. Unpaired t-tests were used to compare
group differences in 1) basal firing rate, 2) change of MAP needed to
silence discharge (MAP Cut-Off), 3) maximum firing rate during
baroreceptor unloading, and 4) MAP needed to produce the maximum
firing rate during baroreceptor unloading. Resting discharge was
determined to be cardiac cycle-related by constructing post-ECG
R-wave triggered time or phase histograms of unit discharge (Spike2
v5.15; Cambridge Electronics Design). Discharge was considered
cardiac rhythmic when a cardiac cycle periodicity was evident in
which the maximum and minimum discharge bins deviated by more
than 20% from the mean firing rate. Baroreflex function curves
relating unit discharge frequency to MAP were constructed by map-
ping unit discharge into 10-mmHg bins of simultaneously recorded
MAP as previously described (50). For illustrative purposes, a Boltz-
mann sigmoid function was used for curve fitting. Group differences
of discharge within specific MAP bins were analyzed by two-way
ANOVA. Pair-wise comparisons were made using the Fisher least-
significant different post hoc test. Data values throughout the text and
figures are expressed as means  SE.
RESULTS
Effect of ANG II plus salt versus sham treatment on MAP
and HR. Figure 1A shows summary data of 24-h averaged
MAP values recorded by telemetry in sham-treated NT rats
(n  9) and HT rats (n  15) treated with ANG II and a
high-salt diet. During a 6-day baseline period, MAP was
similar in NT (98  1 mmHg) and HT (103  2 mmHg) rats.
Heart rate values at baseline (not shown) were also similar
across groups (NT, 415  5 beats/min; HT, 408  5 beats/
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min). Whereas MAP and HR values in NT rats did not deviate
significantly from baseline during the 14 days of vehicle infusion,
administration of ANG II in the HT group significantly increased
MAP to 123 3 mmHg by day 3 and to 133 4 mmHg by day
14 (P 0.001). ANG II infusion had no effect on HR. Figure 1B
shows that although anesthesia lowered MAP more in HT than
NT rats, the average value during RVLM recordings remained
significantly greater in ANG II-salt HT rats than NT controls (P
0.01).
Identification and distribution of recorded neurons. Record-
ings were made from 57 identified RVLM neurons: 34 from
NT and 23 from HT rats. Recordings were made posterior to
the caudal pole of the facial nucleus, which was located by
mapping the antidromic field potential evoked by electrical
stimulation of the facial (CN VII) nerve. An example is shown
in Fig. 2A. Standard criteria were used to classify recorded
neurons as subserving sympathoexcitatory vasomotor function.
Figure 2B shows that neurons were antidromically activated by
electrical stimulation of the dorsolateral funiculus at the T1–2
spinal segment on the side ipsilateral to the brain stem record-
ing site. Antidromic spikes exhibited invariant onset latency
and the ability to follow high-frequency spinal stimulation
(compare top, middle, and bottom traces in Fig. 2B, left). The
average antidromic onset latency was not different between
neurons from NT (24  5 ms; n  9) and HT (33  6; n  6)
rats. Neurons in the NT and HT group had axonal conduction
velocities that averaged 2.0  0.5 m/s and 1.2  0.2 m/s,
respectively, indicating that most had unmyelinated axons.
Figure 2B also shows that evoked spikes underwent time-
controlled collision with spontaneous action potentials, thus
confirming their antidromic nature. Figure 2C shows that
neurons were further characterized as sympathoexcitatory by
having spontaneous discharge that was strongly inhibited when
arterial baroreceptor inputs were activated by raising ABP.
Figure 2D shows the location of recorded neurons that met the
above criteria. They were consistently located within 	700
m of the caudal pole of the facial nucleus, between 1.7 and
2.1 mm lateral to midline and within 	1.0 mm of the ventral
surface of brain. Neurons in NT and HT rats had similar
distributions.
Cardiac entrainment of neuronal discharge. Figure 3A
shows inhibition of spontaneous discharge by raising ABP in
an NT and HT rat. Figure 3B shows that discharge of the same
cells was strongly correlated with the cardiac cycle. Raw data
traces from the NT and HT rat show that each recorded cell
fired a single spike during each cardiac cycle. Post-R-wave
triggered time histograms revealed that these cells fired mostly
during the mid-late systolic rise of ABP. Summary data in Fig.
3C are reported as phase histograms of spontaneous discharge
recorded at resting MAP. Among 34 cells in NT and 23 cells
in HT rats, discharge probability was relatively constant during
the first 	40% of each cardiac cycle, but fell thereafter in each
group to reach a nadir after 	60% of the cardiac cycle had
elapsed. There was no significant difference (F  0.5885) in
the patterning of cardiac rhythmic discharge across neurons
from NT and HT groups. Figure 3D shows that despite HT rats
having higher resting MAP than NT rats (see Fig. 1B), spon-
taneous discharge frequency was similar (P  0.5689) across
groups (NT, 9.5 1.8 spikes/s, n 34; HT, 8.0 1.6 spikes/s,
n  23).
Barosensitivity of neuronal discharge. Given that the fre-
quency and cardiac rhythmicity of spontaneous discharge re-
corded at resting MAP were similar in NT and HT rats, we next
determined whether differences in sensitivity to baroreceptor
inhibition could be detected. Increasing ABP silenced ongoing
discharge of 	82% (28 of 34) of neurons in the NT group and
	74% (17 of 23) of neurons in the HT group. Even among the
six neurons from each group whose discharge was not silenced,
raising ABP reduced discharge by more than 50%. The in-
crease of MAP needed to silence neuronal discharge was
deemed “MAP Cut-Off”. An example is shown in Fig. 4A.
Figure 4B shows that the average MAP Cut-Off value was
significantly greater (P  0.01) in the ANG II-salt HT group
(
44  5 mmHg; n  17) compared with the NT group
(
29  3 mmHg; n  28).
Fig. 1. Effect of ANG II combined with a high-salt diet and sham treatment on
mean arterial pressure (MAP) in conscious and anesthetized rats. A: baseline
values of MAP were recorded by radio telemetry for 6 days before initiating 14
days of subcutaneous infusion of vehicle (normal saline; NT, Œ) or ANG II
(150 ng·kg1·min1; HT, ). Values of MAP in NT and HT rats were similar
at baseline (note that error bars are smaller than symbols). In vehicle-infused
NT rats that consumed a normal salt (0.4% NaCl) diet, MAP values throughout
the infusion period did not deviate significantly from baseline. In ANG
II-infused HT rats that consumed a high-salt (2% NaCl) diet, MAP values
increased during the first 	5 days of treatment. Thereafter, MAP remained
stably elevated such that values were significantly greater than sham-treated
controls (*P  0.001). B: during cell recording experiments, resting MAP
under urethane/chloralose anesthesia remained significantly elevated in HT
(black bar) compared with NT (white bar) rats (*P  0.01).
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Among a subgroup of neurons silenced by raising ABP,
sodium nitroprusside was used to lower ABP and unload
arterial baroreceptors. An example is shown in Fig. 4C. Sum-
mary data in Fig. 4D reveal that the maximum baro-unloaded
firing rate was similar in NT (17.4  4.1 spikes/s; n  15) and
HT (15.3  4.1 spikes/s; n  12) groups (P  0.7227). The
level of MAP needed to achieve maximum baro-unloaded
firing rate was also similar (P  0.4654) between groups (NT,
62  3 mmHg; HT, 65  4 mmHg). Figure 4E shows
summary baroreflex function curves for each group (NT, 34
cells; HT, 21 cells). Note that across a wide range of MAP
values, discharge frequency among identified RVLM neurons
did not differ significantly across groups. However, discharge
of neurons in the HT group did exceed that of neurons in the
NT group (P  0.05) at values of MAP that just exceeded
baseline (range, 120–150 mmHg).
Chemical phenotyping of recorded neurons. The adrenergic
phenotype (C1 or non C1) was determined for a subset of
recorded neurons recovered after successful juxtacellular la-
beling. An example is shown in Fig. 5A. Of 19 recovered
neurons, three from NT rats and six from ANG II-salt HT rats
were PNMT positive and thus were designated C1 cells (Fig.
5B, left). The remaining 10 cells, four from NT and six from
HT rats, did not show detectable PNMT immunoreactivity and
were classified as non-C1cells (Fig. 5B, right). Although there
was a trend for non-C1 cells to fire faster than C1 cells in both
NT and HT groups, summary data in Fig. 5C indicate no
significant group differences in discharge of C1 (NT, 5.8 1.6
spikes/s; HT, 6.8 3.5 spikes/s; P 0.8838) and non-C1 (NT,
10.1 1.6 spikes/s; HT, 9.8 2.9 spikes/s; P 0.9596) cells.
DISCUSSION
Studies in animals (14, 16, 18, 23, 68) and humans (18, 20,
51, 57) demonstrate that neurogenic mechanisms contribute to
the pathophysiology of arterial hypertension. Despite abundant
evidence that neurons of the RVLM are the dominant control-
lers of vasomotor SNA and cardiovascular function (5, 16, 22,
23, 49, 58, 68), direct evidence that their spontaneous dis-
charge frequency is increased in experimental hypertension is
lacking. Here we report that although maintenance of ANG
II-salt hypertension depends on ongoing SNA (39, 40), iden-
tified RVLM vasomotor neurons in HT rats exhibit only a
modest resistance to arterial baroreceptor inhibition with no
increase in resting discharge compared with NT controls.
Consistent with previous reports (12, 29, 30, 40, 41, 68),
resting MAP and HR in the present study were similar among
rats that consumed a high-salt (2% NaCl) and a normal salt
(0.4% NaCl) diet. Upon infusion of ANG II, MAP increased
rapidly in the high-salt group, reaching a stable level after 	5
days. HR was unchanged as previously reported (12, 29, 30,
40, 41). These temporal patterns are again consistent with
previous reports (12, 29, 30, 40, 41, 68) but contrast with
vehicle infused/untreated rats in which both MAP and HR
remained at the baseline level throughout the 14-day treatment
period.
Maintenance of ANG II-salt hypertension critically depends
on ongoing SNA. Studies demonstrate that plasma norepineph-
rine increases along with MAP (29) and that denervation of
splanchnic organs by celiac ganglionectomy also prevents the
delayed plateau phase of the hypertension (30). Direct evi-
Fig. 2. Identification and distribution of rostral ventrolateral medulla (RVLM)
neurons. A: RVLM vasomotor neurons are clustered just caudal to the facial
nucleus, the caudal pole of which was mapped according to the amplitude of
the antidromic field potential evoked by electrical stimulation of the facial
nerve (CN VII). X, approximate location of recording sites (see brain stem
profile to the right); , stimulus artifacts. Note that the amplitude of the
antidromic field potential decays as the recording electrode is moved to more
posterior sites within the facial nucleus and disappears when the most caudal
boundary of the nucleus is reached. B: RVLM vasomotor neurons have axonal
projections to spinal cord. Spinally projecting neurons (NT, n  9; HT, n  6)
were identified by recording antidromic spikes evoked by stimulation of the T2
spinal segment. The antidromic nature of evoked spikes was confirmed by the
consistent onset latency of spikes relative to each stimulus artifact (, at left
and right), their ability to follow high frequency (333 Hz) stimulation (middle
and lower traces at left), and collision with spontaneous action potentials (at
right; *sweeps where collision occurred). C: spontaneous discharge of re-
corded RVLM neurons was consistently inhibited by raising arterial blood
pressure (ABP). D: recorded RVLM neurons in NT (Œ) and HT () rats were
similarly distributed and consistently located within 	700 m of the caudal
pole of the facial nucleus, 1.7–2.1 mm lateral to midline and within 1.0 mm of
the ventral surface of brain. Note that x- and y-axis values are distances (in
mm) relative to bregma and brain surface, respectively. AU, arbitrary units.
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dence that sympathetic outflow to splanchnic organs is in-
creased in ANG II-salt hypertension is lacking (70), but studies
have reported that splanchnic vascular resistance is increased
(31, 39). Although the latter might not result from elevated
splanchnic SNA, it is presumed to be sufficient to support
elevated MAP since chronic recordings in conscious rats indi-
cate that renal SNA falls and lumbar SNA is unchanged during
development of ANG II-salt hypertension (70). Collectively,
evidence suggests that neurogenic mechanisms develop grad-
ually and contribute to maintenance of ANG II-salt hyperten-
sion. Importantly, the contribution of SNA to support of ANG
II-salt hypertension does not appear to solely reflect increased
vascular reactivity to released norepinephrine since interrup-
tion of neural activity in specific brain regions selectively
blunts the delayed neurogenic phase of the hypertension (41,
43, 44).
Studies document that RVLM vasomotor neurons are lo-
cated just posterior (within	700 m) to the caudal pole of the
facial nucleus and have specific characteristics that include
monosynaptic excitatory connections to spinal sympathetic
Fig. 3. Barosensitivity and cardiac rhythmicity of RVLM neuronal discharge. A: example of the response of a recorded neuron in an NT (left) and HT (right)
rat. Note that in both case discharge was silenced when ABP was raised by inflating an aortic cuff. B: example traces of ABP, ECG (lead II), and cell discharge
show that neurons in NT (left) and HT (right) rats fired with a consistent temporal relation to cardiac depolarization (R waves) and pulsatile ABP. R-wave
triggered time histograms of unit discharge reveal that spontaneous discharge in the NT (left) and HT (right) rat was strongly cardiac rhythmic. C: summary
R-wave triggered phase histograms constructed from 34 cells recorded in NT rats (left) and 23 cells recorded in HT rats (right). Note that pulse rhythmic
baroreceptor inhibition produced a similar magnitude reduction of discharge probability in both groups, with the nadir consistently occurring after 	60% of the
cardiac cycle period had elapsed. D: summary data reveal that the average resting discharge frequency among identified RVLM vasomotor neurons was similar
in cells from NT (white bar) and HT (black bar) rats.
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preganglionic neurons along with cardiac rhythmic and baro-
receptor inhibitable spontaneous discharge (9, 10, 37). Neurons
recorded in the present study shared these properties. Due to
the important role RVLM neurons play in cardiovascular
regulation, we hypothesized that their hyperactivity could lead
to increased SNA and thereby contribute to maintenance of
ANG II-salt hypertension. Consistent with this hypothesis,
studies have shown that acute inhibition of RVLM dramati-
cally reduces ABP in several experimental models of hyper-
tension (6, 7, 25, 26, 59). But despite such evidence, a previous
study reported that spontaneous discharge frequency of RVLM
vasomotor neurons did not differ between NT rats and SHR
(64). As in the SHR study, we also found no difference in
resting discharge between NT and ANG II-salt HT rats among
a similar population of recorded RVLM neurons. Drawing
parallels between these two studies is complicated by several
factors. First, SHR are an inbred strain used to model essential
hypertension. Thus substantial genetic differences between
SHR and the Sprague-Dawley rats used in the present study
could confound direct comparisons. In addition, whereas re-
cordings in SHR were performed under halothane anesthesia,
our rats were anesthetized with a mixture of -chloralose and
urethane. This raises several issues. First and most important is
that both anesthetics reduced MAP more in the HT group than
in NT controls. Thus anesthesia might have prevented detec-
tion of differences in resting discharge that could have existed
while rats were conscious. Another issue to consider is that
under halothane anesthesia resting discharge of RVLM neu-
rons in both SHR and normotensive Wistar-Kyoto rats was
more than twice that reported when other anesthetics are used,
including -chloralose/urethane used in the present study (10,
33, 35, 37). Thus inhibitory and excitatory efficacy of inputs to
RVLM in the SHR study could have been compromised,
thereby shifting the balance of control in favor of excitation
relative to the present study, again confounding direct compar-
ison.
Despite these experimental differences, results of the two
studies overall were nevertheless remarkably similar. Both
studies indicate that regulation of RVLM neuronal discharge
by arterial baroreceptors was mostly intact in HT compared
with NT rats. In both studies, the pressor level required to
silence neurons was higher in HT rats, indicating that barore-
ceptor inhibition of these neurons was blunted, but not enough
to result in a significant increase of resting discharge at the
prevailing level of baseline MAP. Whether attenuation of
baroreceptor inhibition was due to reduced mechano-transduc-
tion of baroreceptor endings, blunted transmission of barore-
ceptor inputs, or reduced postsynaptic response to baroreceptor
inhibition is not presently known. Certainly a combination of
these factors could be involved. It should also be emphasized
that because resting MAP was higher in rats with ANG II-salt
hypertension, smaller increments were required to raise MAP
to specific levels above baseline. Consequently, higher dis-
charge values at elevated MAP in HT rats could simply reflect
less recruitment of baroreceptor inputs rather than a specific
biological mechanism conferring resistance of RVLM neurons
to baroreceptor inhibition.
Whichever the case might be, blunted inhibitory modulation
in the present study was apparent only across a narrow range of
MAP that just exceeded the resting value under anesthesia. It
seems unlikely that this would account for exaggerated SNA
that contributes to ANG II-salt hypertension. It should be
emphasized, however, that the narrow range of MAP over
which significant blunting of baroreflex inhibition was evident
in the present study closely overlapped with the level of
hypertension recorded by telemetry while rats were conscious.
This suggests that inhibitory efficacy of baroreceptor inputs
might be selectively blunted in ANG II-salt HT rats at levels of
MAP that lie close to the prevailing level of chronic hyperten-
sion. Whether this could be a contributing or permissive factor
in the development/maintenance of the hypertension or is
simply an adaptive or compensatory response to the hyperten-
Fig. 4. Comparison of barosensitivity of RVLM neuronal discharge. A: ex-
ample data show that raising ABP by inflation of an aortic cuff led to silencing
of discharge. The change of MAP required to silence cell discharge was
deemed “MAP Cut-Off.” B: summary data for 28 neurons from NT rats
(white bar) and 17 neurons from HT rats (black bar) indicate that a signifi-
cantly (*P  0.01) greater increase of MAP was required to fully silence
neurons in the HT group. C: example traces show that intravenous injection
of the vasodilator sodium nitroprusside (SNP) consistently lowered AB and
increased discharge of identified RVLM neurons. D: summary data of maxi-
mum firing rate achieved during SNP-induced unloading of arterial barorecep-
tors. Note that discharge increased similarly among neurons in NT (white bar)
and HT (black bar) rats. E: summary baroreflex function curves relating MAP
to RVLM discharge frequency. Note that NT (Œ) and HT () groups had
similar maximum discharge frequency during baroreceptor unloading and
similar minimum discharge frequency when MAP as raised. Neurons in the
ANG II-salt HT group showed a significant degree of resistance to baroinhi-
bition across values of MAP ranging from 120 to 150 mmHg.
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sion requires further investigation. Although evidence clearly
indicates that circulating and brain-derived ANG II are capable
of acutely and chronically modifying arterial baroreflex control
of SNA in a variety of species (4, 8, 34, 36), studies to date
have not documented specific baroreflex alterations (e.g., gain,
set point, functional range, etc.) in the same rat model of ANG
II-salt hypertension used in the present study. A final consid-
eration is that ANG II-salt hypertension is presumed to rely on
a selective increase of splanchnic SNA (30, 39, 40, 70). If this
is ultimately proven correct, then it would seem possible that a
specific subpopulation of RVLM neurons might exist that
selectively supplies exaggerated sympathetic traffic to splanch-
nic organs in ANG II-salt HT rats. That being the case, then it
would seem that we either entirely failed to detect such neurons
or that they were not sufficiently enriched within the popula-
tion of recorded cells to have produced a statistically greater
average firing rate in the ANG II-salt HT group compared with
controls.
There is substantial evidence that both circulating ANG II
and high salt intake strongly influence cardiovascular homeo-
stasis. Circulating ANG II and hypertonic NaCl both activate
neurons of the hypothalamic PVN through excitatory projec-
tions from the subfornical organ (17, 46, 55, 66) and ventral
forebrain (1, 56, 61). Once activated, PVN neurons could
increase SNA and ABP through projections to a variety of
downstream targets, most notably RVLM vasomotor neurons
and spinal sympathetic preganglionic neurons (13, 15, 45, 47,
54, 60, 65). Differentiating between these possibilities requires
further investigation, but the present results suggest either that
SNA is not elevated in ANG II-salt HT rats or that pathways
not involving RVLM could participate. The possibility that
RVLM neurons do not drive neurogenic contributions to ANG
II-salt hypertension is consistent with their resting discharge
being similar among NT and HT rats and with our observation
that their maximal discharge during baroreceptor unloading
was also similar across groups. During baroreceptor unloading,
RVLM neurons are effectively devoid of their dominant source
of ongoing inhibition. Under these conditions, their discharge
would be expected to most strongly reflect convergent drives
descending from ANG II and sodium-sensitive regions of the
forebrain and hypothalamus. Yet, even under these conditions,
no group difference in RVLM neuronal discharge frequency
was detected. We acknowledge that this does not fully elimi-
nate the possibility that excitability/excitatory drive is en-
hanced among RVLM vasomotor neurons in conscious ANG
II-salt HT rats. However, results are consistent with the pos-
sibility that RVLM neurons and feed-forward sympathoexcit-
atory neurons of the forebrain/hypothalamus might operate in
parallel in ANG II-salt hypertension such that descending
sympathoexcitatory drives largely bypass RVLM. There is
evidence to support such a possibility (28, 48), but to our
knowledge not in the specific case of neurogenic hypertension.
In sum, results of the present study indicate that combined
treatment with systemic ANG II and a high-salt diet does not
Fig. 5. Neurochemical phenotyping of RVLM neurons. A: example traces
illustrate the juxtacellular labeling technique. Discharge of a representative
RVLM neuron is shown at rest (top traces), during delivery of positive current
pulses through the recording electrode to entrain discharge (during which the
recorded neuron is filled with biotinamide [middle traces]), and during recov-
ery (bottom traces). B: histological processing of brain tissue was performed to
recover recorded neurons that were successfully filled with biotinamide using
the juxtacellularly labeling technique (at top; green). Immunohistochemical
processing of the same tissue sections revealed the presence of the epinephrine
synthetic enzyme phenylethanolamine-N-methyl transferase (PNMT), thereby
marking the location of C1 cells (at middle; red). Merged images (bottom)
reveal double-labeled neurons that belong to the C1 cell group (at left; yellow)
and nondouble labeled neurons that do not (at right; green). C: summary data
show that resting discharge frequencies were similar among C1 and non-C1
neurons from NT and HT rats. IR, immunoreactivity.
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change resting discharge frequency of identified RVLM vaso-
motor neurons. As indicated above, this conclusion must be
tempered by the fact that recordings were made in anesthetized
rats. Of note, anesthesia lowered resting MAP more in ANG
II-salt HT than NT rats, and this could reflect a greater
anesthesia-induced reduction of RVLM vasomotor neuron dis-
charge in the HT group. Such an effect could have effectively
masked a difference in resting discharge between groups. An
argument against anesthesia having a generalized effect to
blunt neuronal excitability is that maximal discharge frequency
during complete baroreceptor unloading did not differ in NT
and HT rats. Our observation that the resting discharge of
RVLM vasomotor neurons did not differ among ANG II-salt
hypertensive and normotensive rats suggests either that SNA is
not elevated in ANG II-salt hypertension or that any increase of
SNA that contributes to the hypertension is driven by sympa-
thetic premotor neurons that reside outside of RVLM. In
addition, pre- and/or postganglionic sympathetic neurons that
lie distal to RVLM could undergo adaptive changes in rats with
ANG II-salt hypertension such that they exhibit exaggerated
responses to inputs they receive, be they inputs from RVLM or
other sympathetic regulatory regions of brain. Consistent with
evidence from recordings in SHR (64), we conclude that
exaggerated resting discharge of RVLM vasomotor neurons
does not contribute to neurogenic ANG II-salt hypertension. Of
note, this conclusion appears to extend to both C1 and non-C1
neurons.
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